Displaying 2161 - 2180 of 4745
FTC Staff Provides Public Comment and Testimony in Tennessee Opposing Certificate of Public Advantage Application
Tennessee Department of Health Public Hearing Testimony
FTC Staff Submission to the Tennessee Department of Health Regarding the Certificate of Public Advantage Application of Mountain States Health Alliance and Wellmont Health System
16110005 Informal Interpretation
16110004 Informal Interpretation
FTC Approves Application from HeidelbergCement AG and Italcementi S.p.A. to Divest Martinsburg, West Virginia Cement Facility and Related Assets
HeidelbergCement AG and Italcementi S.p.A., In the Matter of
German cement producer HeidelbergCement AG and Italian producer Italcementi S.p.A. agreed to divest a cement plant in Martinsburg, WV and up to 11 cement distribution terminals in six other states to settle charges that their proposed $4.2 billion merger would likely harm competition in five regional markets for cement in the United States. Heidelberg and Italcementi are the second and fourth largest producers of cement in the world, and in the United States, the two companies compete through their respective U.S. subsidiaries, Lehigh Hanson and Essroc Cement Corp., to sell portland cement – an essential ingredient in making concrete. According to the FTC complaint, the merger as proposed would harm competition for portland cement in five metropolitan areas: Baltimore-Washington, DC; Richmond, Virginia; Virginia Beach-Norfolk-Newport News, Virginia; Syracuse, New York; and Indianapolis, Indiana. In each of these markets, the FTC alleges the merger as originally proposed would have reduced the number of competitively significant suppliers from three to two. The proposed consent agreement requires the merged company to divest to an FTC-approved buyer an Essroc cement plant and quarry in Martinsburg, West Virginia; seven Essroc terminals in Maryland, Virginia and Pennsylvania; and a Lehigh terminal in Solvay, New York. At the buyer’s option, the order also requires the merged company to divest two additional Essroc terminals in Ohio. Under the proposed order, these divestitures must occur within 120 days after the merger is complete. In addition, the merged company has ten days after the merger is complete to divest Essroc’s terminal in Indianapolis to Cemex, Inc.
16110003 Informal Interpretation
FTC Amicus Brief Urges Appeals Court to Reverse District Court’s Dismissal of Amphastar Pharmaceuticals, Inc. v. Momenta Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc., et al. v. Momenta Pharmaceuticals, Inc., et al.
FTC Requires Parent Company of Bausch + Lomb to Divest Paragon
16110002 Informal Interpretation
16110001 Informal Interpretation
FTC and DOJ Seek Public Comment on Proposed Revisions to International Antitrust Guidelines
Statement from Federal Trade Commission’s Bureau of Competition Director on Appeals Court Decision to Remand Advocate/North Shore Hospital Merger Case to District Court for Further Action
FTC Approves Modified Final Order Preserving Competition among Supermarkets in Seven States
FTC Files Joint Amicus Brief with U.S. Department of Justice in Supreme Court Cases Involving Visa and MasterCard
Investment Firm Founder Fayez Sarofim to Pay $720,000 to Settle FTC Charges For Violation of U.S. Premerger Notification Requirements
Displaying 2161 - 2180 of 4745